Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ThermoGenesis Holdings (THMO)
OTHER OTC:THMO
Holding THMO?
Track your performance easily
THMO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.13 - $1.41
Previous Close$0.17
Volume85.00
Average Volume (3M)14.67K
Market Cap
$2.70M
Enterprise Value$6.39M
Total Cash (Recent Filing)$1.18M
Total Debt (Recent Filing)$6.93M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Nov 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.75
Shares Outstanding15,850,000
10 Day Avg. Volume14,074
30 Day Avg. Volume14,666
Standard Deviation2.81
R-Squared0.02
Alpha0.42
Financial Highlights & Ratios
Price to Book (P/B)4.32
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio1.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda-1.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ThermoGenesis Holdings News
PremiumCompany Announcements
ThermoGenesis Board Shake-Up Amid Governance Concerns
PremiumCompany Announcements
Haihong Zhu Steps Down as ThermoGenesis Board Director
PremiumPre-Earnings
Is THMO a Buy, Before Earnings?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
THMO FAQ
What was ThermoGenesis Holdings’s price range in the past 12 months?
ThermoGenesis Holdings lowest stock price was $0.13 and its highest was $1.41 in the past 12 months.
What is ThermoGenesis Holdings’s market cap?
Currently, no data Available
When is ThermoGenesis Holdings’s upcoming earnings report date?
ThermoGenesis Holdings’s upcoming earnings report date is Nov 13, 2024 which is in 54 days.
How were ThermoGenesis Holdings’s earnings last quarter?
Currently, no data Available
Is ThermoGenesis Holdings overvalued?
According to Wall Street analysts ThermoGenesis Holdings’s price is currently Overvalued.
Does ThermoGenesis Holdings pay dividends?
ThermoGenesis Holdings does not currently pay dividends.
What is ThermoGenesis Holdings’s EPS estimate?
ThermoGenesis Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ThermoGenesis Holdings have?
ThermoGenesis Holdings has 15,847,517 shares outstanding.
What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ThermoGenesis Holdings?
Currently, no hedge funds are holding shares in THMO
---
ThermoGenesis Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.05%
12-Months-Change
Fundamentals
Return on Equity
-417.94%
Trailing 12-Months
Asset Growth
-48.93%
Trailing 12-Months
Company Description
ThermoGenesis Holdings
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
---
THMO Earnings Call
Q3 2023
0:00 / 0:00
---
THMO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Cellectar Biosciences
―
Soligenix
―
Atossa Therapeutics
―
Brainstorm Cell Therapeutics
―
Best Analysts Covering THMO
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-70.42%
reiterated a buy rating 10 months ago
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.42% per trade.
---